. OA has long been viewed as the consequence of 'wear and tear' on cartilage together with the incapacity of cartilage to repair itself. However, we now know that OA is a disease of the whole joint, involving not only cartilage but also the synovial tissue, tendons, ligaments and the subchondral bone 4 . Interestingly, whereas articular cartilage is not innervated or vascularized, the synovial tissue and the subchondral bone are. Moreover, OA was considered a local disease influenced solely by mechanical processes, such as in OA acquired as a result of overload caused by obesity or joint trauma, or congenital OA resulting from defects such as dysplasia or limb deformity. In this view of OA, local production of the inflammatory mediators found in OA synovial fluid is the consequence of a foreign-bodylike reaction of the synovial tissue to cartilage fragments released in the joint cavity during the matrix-destructive OA process. These mechanical and inflammatory local factors are known to be critical for the initiation and progression of OA; however, studies in the past decade have shown that systemic factors belonging to hormone or cytokine families also contribute to the local destructive process, with the particular roles of these systemic factors varying according to the phenotype of the disease 4 . For example, low-grade systemic inflammation involving adipose tissue and insulin resistance is frequently observed in unhealthy obese patients with metabolic disorders (diabetes, hyperlipidaemia and hypertension) 5, 6 . Interestingly, obesity is a risk factor for hand OA, which is probably related to the role of elevated circulating adipokines in obese individuals 7 . Moreover, the presence of metabolic disorders increases the risk of OA in obese patients, strengthening the hypothesis that systemic factors have an additive or synergic role in the destructive process of OA 8 . Dysregulation of microbiota induced by obesity has also been suggested to play a part in the pathogenesis of OA. This dysregulation causes an increased concentration of systemic lipopolysaccharides, leading eventually to the activation of joint cells 9 . Finally, the cytokines produced by an OA joint and released into the circulation could affect organs at a distance from the joint, such as the brain 10, 11 . Together with obesity, ageing is a major risk factor for OA. Enrichment of cartilage matrix with advanced glycation end-products could explain in part the cartilage fragility induced by ageing 12 . In parallel, modifications to chondrocyte metabolism occur with age. Senescent chondrocytes become more sensitive to cytokines, leading to increased synthesis of cytokine-induced matrix metalloproteinases 13 . Moreover, the chronic lowgrade inflammation that develops with age might further compromise joint tissue homeostasis 14 . Literature in the past decade has highlighted a critical role of the central and peripheral nervous systems, including the circadian clock system, in maintaining rhythmic behaviour (for example, sleep-wake cycles) and daily metabolism (such as weight, energy expenditure, blood glucose concentration and blood pressure). Joint tissue is highly mechanically regulated, going through daily phases of activity and inactivity controlled by 24 h rhythms generated in the brain. Age-related decline in brain function, including that of the circadian system, could affect the homeostasis of joint tissues.
In view of the potential links between OA and metabolic disorders, and between metabolic disorders and the nervous system and circadian system (FIG. 1) , this article reviews current knowledge of the direct and indirect roles of the nervous system and circadian system in the initiation and/or progression of OA, and highlight potential directions of future research on this emerging topic.
Overview of brain-periphery circuits
The autonomic nervous system. The nervous system consists of two main parts: the central nervous system (CNS), comprising the brain and the spinal cord, and the peripheral autonomic nervous system (ANS), which includes sympathetic and parasympathetic nerves. Some parts of the nervous system are more focused on communications with peripheral organs and tissues, such as the hypothalamus and autonomic nerves.
Adrenaline and noradrenaline (adrenaline and noradrenaline), the main sympathetic neurotransmitters, provoke an increase in heart rate and blood pressure, and decrease digestive function by interacting with adrenergic receptors. By contrast, acetylcholine, the principal parasympathetic neurotransmitter, interacts with muscarinic acetylcholine receptors to produce the opposite effects. The physiological function of an organ thus depends on a sophisticated system that integrates opposing signals.
Interestingly, along with these well-known autonomic reflex arcs, an inflammatory reflex involving the vagus nerve has been described 15 . It consists of an afferent sensory neural arc that detects the chemical products of injury, infection and inflammation, and an efferent motor neural arc that transmits signals to modulate immune responses.
Circadian clocks. In order to regulate sleep and activity in a 24 h period, a master clock, influenced by light and darkness from sunrise to sunset and located in the suprachiasmatic nucleus (SCN) of the hypothalamus, delivers rhythmic signals to brain regions influencing locomotor activity, feeding behaviour, hormone secretion and body temperature 16, 17 . The various rhythmic biological processes are driven by the expression of clock genes. The transcription and repression of these clock genes are induced by a transcriptional-translational feedback loop 18, 19 . This loop consists of a positive arm (involving the transcription factors CLOCK and BMAL1, also known as aryl hydrocarbon receptor nuclear translocator-like protein 1), a negative arm (involving the period and cryptochrome proteins) and an auxiliary stabilizing loop (involving the nuclear receptor subfamilies REV-ERBs and RORs). Most of these clock factors are transcription factors or nuclear hormone receptors with a limited half-life that enables their daily oscillation and turnover. In addition to the self-perpetuating regulation of the clock genes, components of the molecular circadian clock control various clock-controlled genes through response elements in their promoters or post-translational mechanisms.
Interestingly, knowledge of the role of this central pacemaker has tremendously expanded in the past few years owing to the discovery of secondary self-sustained autonomous circadian clocks present in the peripheral tissues 20 . These circadian clocks need to be reset by the central master clock on a daily basis in order to maintain synchrony. By means of humoral and neural circuits, the central master clock exerts tight temporal control of the peripheral circadian clocks 21, 22 (FIG. 2) . For instance, glucocorticoid signalling is rhythmically controlled by the SCN and can act as a systemic entrainment factor for peripheral clocks 21, 23 . As a demonstration of this fact, circadian rhythms in peripheral tissues of adrenalectomized rats demonstrate phase changes and desynchrony 22 . Moreover, time cues other than daylight, such as feeding-fasting cycles, can influence the rhythmicity of the master clock, which explains how intrinsic and extrinsic factors can modulate our metabolism [24] [25] [26] [27] . Daily feeding signals can strongly entrain peripheral clocks in certain tissues, such as the liver and colon 25, 26 . Core body temperature rhythm has also been suggested as a potential synchronizing factor for peripheral tissues and cells (but not for the SCN) 28 . Of note, the cholinergic anti-inflammatory reflex arc has been linked to circadian rhythm regulation. Indeed, circadian rhythmicity exists in the cholinergic system, characterized by high acetylcholine release and low activity of the acetylcholine degrading enzyme acetylcholinesterase during the active phase (that is,
Key points
• Osteoarthritis (OA) is an active disease of the whole joint that is subject to both local and systemic regulation • The nervous system controls key aspects of joint pathophysiology by regulating circadian rhythms, the hypothalamic-pituitary-adrenal axis, and metabolic and inflammatory pathways • Ageing, obesity and chronic inflammation interfere with the brain-joint axis (including the circadian system), which compromises joint homeostasis and increases susceptibility to OA • Circadian clocks in the central brain and peripheral joint tissues temporally coordinate local physiology to the daily rhythmic environment (light-dark, feeding-fasting, body temperature regulation and mechanical loading cycles) • Environmental or genetic disruption to the biological timing system might be a novel risk factor for OA susceptibility • Targeting the nervous system or circadian system could provide novel therapeutic avenues for OA 29 . Furthermore, cholinergic stimuli are potent regulators of the master clock in the SCN 30, 31 .
The hypothalamic-pituitary-adrenal axis. The physiological interactions that occur between three endocrine glands, the hypothalamus, the pituitary gland (located below the hypothalamus) and the adrenal glands, are termed the hypothalamic-pituitary-adrenal (HPA) axis. This axis controls many physiological processes including digestion, immune reactions, energy storage and expenditure, and circadian timing. The circadian system and the HPA axis communicate with each other at multiple signalling levels 32, 33 . The HPA axis has critical roles in transmitting rhythmic signals generated by the SCN to the rest of the brain and body. Activated by corticotropin-releasing hormone, a hormone secreted by the hypothalamus under the control of the circadian clock, the pituitary gland releases adrenocorticotropic hormone into the bloodstream, which induces the production of cortisol by the adrenal glands. Consequently, the diurnal profile of cortisol helps entrain peripheral tissue clocks. The HPA axis can also be activated by circulating cytokines such as IL-1, IL-6 or TNF, leading to a physiological negative feedback loop created by the immunomodulatory and anti-inflammatory properties of cortisol 34, 35 . Importantly, cortisol and cytokines both have strong circadian profiles, supporting an integral crosstalk between the circadian timing system and the HPA axis.
The hypothalamic-pituitary-thyroid axis. Thyroid hormones physiologically act on epiphyseal chondrocytes by stimulating differentiation and inhibiting proliferation. In the past decade, a role of thyroid hormones in the pathophysiology of OA has been demonstrated 36 . This assumption is based on the discovery of DIO2 (encoding deiodinase type 2 [DIO2]) as a susceptibility gene for OA. The related DIO2 protein catalizes the inactive T4 hormone into its active form T3, which is involved in cartilage matrix integrity. It is worth noting that the activity of the hypothalamic-pituitary-thyroid axis has long been known to show diurnal variations. More importantly, parathyroid hormone (PTH) regulates the expression of clock genes in growth plate chondrocytes, although its role in articular cartilage remains largely unknown 37 .
Local influence on the OA process Deregulation in the autonomic nervous system. Disruption of the anti-inflammatory vagal reflex has been shown in many autoimmune and inflammatory disorders such as rheumatoid arthritis, inflammatory bowel disease and pancreatitis [38] [39] [40] . Within the past few years, Liu et al. 41 have suggested that an alteration in this inflammatory reflex could also play a part in OA (FIG. 3) . In a rat model, the researchers showed that articular chondrocytes express subunit α7 of the nicotinic acetylcholine receptor, and its stimulation with nicotine inhibits IL-1-induced MAPK and NF-κB activation. Moreover, intraperitoneal injections of nicotine prevented cartilage degradation induced by intra-articular injection of monoiodoacetate, an experimental model of arthritis similar to OA 41 . Further studies in OA animal models are warranted to establish the underlying mechanisms of this inflammatory reflex.
The role of sympathetic nerve fibres present in synovial tissue, the subchondral bone marrow and the meniscus remains mysterious. However, in vitro and ex vivo studies show that ANS-related neurotransmitters can influence chondrogenesis [42] [43] [44] [45] . A few studies have looked at the role of adrenergic receptors present at the surface of chondrocytes, including in human OA cartilage Indeed, β 2 adrenergic receptors and α 2 adrenergic receptors are both expressed on epiphyseal proliferating chondrocytes [44] [45] [46] [47] [48] [49] . Adrenaline inhibits the maturation process of growth plate chondrocytes with downregulation of the expression of type II collagen and Sox6 (REFS 42, 45) . Contradictory results have been reported showing either an upregulation or a downregulation of type X collagen expression with no effect on type II collagen after activation of β 2 adrenergic receptors 44, 49 . Interestingly, binding of noradrenaline on β 2 adrenergic receptors could also affect epiphyseal chondrocyte The joint is an organ that interacts with its environment. Joint homeostasis is under the control of local, humoral and neuronal factors. Dysregulation of these factors and/or an abnormal perception of them locally could provoke a joint degradation process leading to OA. Many of these factors are under the master control of the CNS (control of clock genes from the suprachiasmatic nucleus, the HPA axis, the HPT axis, vagal nerve reflex). Local factors include mechanical cues and advanced glycation end-products. Humoral factors include inflammatory cytokines and growth factors, adipose tissue humoral mediators (adipokines, fatty acids), glucose and insulin levels, and senescence-associated secretory proteins. Neuronal factors include neuromediators. ANS, autonomic nervous system; CNS, central nervous system; HPA axis, hypothalamic-pituitary-adrenal axis; HPT axis, hypothalamic-pituitary-thyroid axis; OA, osteoarthritis. survival by decreasing the apoptosis rate 47 . Moreover, by use of mesenchymal stem cells and cartilage progenitor cells, Jenei-Lanzl et al. 43 have demonstrated that noradrenaline can inhibit chondrogenesis and accelerate hypertrophic differentiation. Collectively, these studies tentatively point towards a role of the ANS in the regulation of OA-related pathways, although unequivocal evidence is still lacking.
Desynchronization of joint tissue-specific clock genes.
The joint tissues (cartilage, tendons and subchondral bone) are particularly influenced by daily rest-activity cycles, which are controlled indirectly by the central brain clock (FIG. 3) . Coupling of local gene expression and physiology to daily cycles of loading-unloading of joints and related metabolic changes could be an important part of joint biology and homeostasis.
As in many other tissues, cartilage homeostasis is under the control of a peripheral circadian clock. A circadian time series transcriptomic analysis of mouse chondrocytes (from xiphoid cartilage) revealed 615 (3.9%) cartilage genes with a circadian pattern of expression 49 . Our own work has shown that this number is an underestimate for articular cartilage in mice that undergoes daily mechanical challenges (Q.-J.M., unpublished work). The rhythmic clock-controlled genes include those involved in extracellular matrix remodelling, apoptosis and oxidative stress pathways 50, 51 . Diurnal variations in serum levels of cartilage oligomeric matrix protein, hyaluronic acid, keratan sulfate, aggrecan, collagen type II and TGFβ have also been reported 52, 53 . Several brain-controlled systemic factors, such as hormone rhythms (for example, glucocorticoids) and core body temperature cycles, are able to entrain the cartilage circadian rhythm 50 . This point is particularly interesting because cartilage is avascular and not innervated. PTH, which exhibits diurnal variation in serum concentration 54 , might be another systemic factor with the capacity to entrain the circadian clock in chondrocytes. In mice, PTH induces Per1 expression in osteoblasts and chondrocytes 55 . A cartilage clock could also potentially be entrained by daily rhythms of activity. In fact, the Clock gene has been identified as a mechanosensitive gene in cultured chondrocytes 56 . Interestingly, dysregulation of a panel of canonical clock genes was found in the early stages of cartilage degeneration in a post-trauma mouse model of OA (by destabilization of the medial meniscus) and in human OA cartilage 41, 57 . Moreover, IL-1, a critical cytokine for matrix metalloproteinase (MMP)-dependent cartilage degradation, disrupts circadian gene expression rhythms accompanied by dysregulated expression of endogenous clock genes in mouse cartilage explants 58 . In addition, a genetic link between the clock factor BMAL1 and articular cartilage health has been established. Conditional loss of chondrocyte BMAL1 leads to selective disruption of cartilage circadian rhythm, associated with progressive degeneration and lesions in the articular cartilage of mouse knee joints 59 Similar to cartilage, bone cells are also influenced by peripheral circadian clocks 60 . Several markers of bone metabolism show diurnal variations in serum, including calcium, osteocalcin, skeletal alkaline phosphatase, PTH and calcitonin 61, 62 . At a transcriptional level, 26% of genes expressed in calvarial bone exhibit near 24 h diurnal oscillations, including genes that encode proteins involved in bone morphogenetic protein, fibroblast growth factor and Wnt signalling pathways, and genes that encode multiple ADAMTS proteases and various pro-collagen isoforms 63 . Moreover, the canonical clock gene Cry2 influences osteoclast activity whereas another canonical clock gene Per2 acts on osteoblasts in mice 64 . A high bone mass phenotype can be seen in double Per1/Per2 or Cry1/Cry2 knockout mice 65 . By contrast, systemic loss of Bmal1, the positive regulator within the clock, leads to a low bone mass phenotype, probably because of the compromised capacity of mesenchymal stem cells to differentiate into osteoblasts 66 . These phenotypes point to a mechanism in which different clock factors regulate bone formation by coordinated actions on the activities of osteoblast and osteoclast. The SCN then generates endogenous circadian time cues that can be transmitted to the peripheral tissues. The peripheral tissues exhibit autonomous circadian clocks that can be entrained by the SCN not only directly (through neuronal innervation), but also indirectly through time cues coming from the environment (for example, hormones, food intake, core body temperature and physical activity). The molecular clock controls a variety of genes and pathways crucial for correct functioning of the tissues in the musculoskeletal system. Mutations of the core clock components can result in a range of pathologies affecting structural components of the tissues, energy metabolism and differentiation along tissue-specific lineages. HPA axis, hypothalamic-pituitary-adrenal axis; OA, osteoarthritis; PTH, parathyroid hormone. The SCN output signals may be transmitted to the local bone clocks through the β-adrenergic (sympathetic) pathway, glucocorticoid signalling, feeding-fasting cycles and changes in leptin levels 67 . Adrenalectomy of mice reduces the amplitude of period genes in osteoclasts, and abolishes rhythmic expression of the osteoclastspecific genes Ctsk (cathepsin K) and Nfatc1, which can be rescued by glucocorticoid injection in vivo 68 . The role of the subchondral bone in the initiation and progression of OA is now well demonstrated. Although not proved, circadian clocks might contribute to the homeostasis of the subchondral bone. Thus, any perturbations in the expression of clock-controlled genes in subchondral bone cells could be potentially deleterious with respect to the initiation and/or progression of OA.
Tendons are another integral part of the joint, providing transmission of forces and maintaining the stability of the joint. In 2014, Yeung et al. 69 described an autonomous circadian clock in mouse tendon tissue and human tenocytes. Importantly, cross-tissue comparison of the rhythmic transcriptomes revealed only ~15% overlap between cartilage and tendon -two closely related skeletal tissues-highlighting the tissue-specific adaptations of the circadian system. Glucocorticoid signalling was shown to be capable of entraining the tendon clock 69 . Additional mechanisms, such as mechanical loading, may well also be at play to synchronize this particular local clock. A calcified tendon phenotype was observed in both global Bmal1 knockout mice 70, 71 and loss-of-function ClockΔ19 mutant mice 69 , supporting the idea that the core circadian clock complex (BMAL1-CLOCK) has a role in regulating tendon physiology. Therefore, rhythm disruptions (for example, during ageing) might lead to compromised tendon function, further reducing joint stability.
Systemic influence on the OA process Circadian rhythm decline with ageing. Ageing is a wellknown intrinsic factor that affects the robustness of circadian rhythms 72 , and clock genes are intimately linked to the ageing process and age-related diseases. For example, global Bmal1 knockout mice demonstrate a premature ageing phenotype, with widespread tissue pathologies, including progressive arthropathy. Such a phenotype was thought to arise from increased stressinduced cellular senescence 73 and increased levels of reactive oxygen species, rendering the cells in Bmal1 knockout mice more susceptible to oxidative stress and DNA damage. ClockΔ19 mutant mice show a metabolic syndrome phenotype, which is another disorder prevalent in the ageing population 74 . During ageing, circadian rhythms deteriorate in animal models and humans as measured by behavioural and physiological outputs such as sleep-wake cycle, body temperature fluctuation or plasma hormone levels 75 . The decline in circadian function is manifest as a reduction in circadian amplitude (or strength) and a change of circadian phase, leading to internal desynchrony or misalignment 76, 77 . The decline of the systemic time cues from the aged SCN may contribute to the dampened circadian rhythms in peripheral tissues, as observed in cartilage 50 and tendon 69 tissues. This notion is further supported by studies in aged skin. For example, Pagani et al. showed that skin fibroblasts from older individuals retained equivalent clock properties in vitro as cells from young individuals 78 . However, application of serum from older donors to the cultured cells from young or older individuals had significantly weaker effects in synchronizing circadian rhythm than serum from young donors 78 , suggesting that changes in systemic factor(s) underlie the dampening of the molecular clock in vivo. However, intrinsic factors, such as cell senescence, may also contribute to the ageing phenotype of skeletal clocks. Aged chondrocytes demonstrate higher levels of stress-induced senescence, producing interleukins (IL-6, IL-1) and proteases (MMPs) that degrade the matrix and contribute to OA 79 . A reduction in brain-controlled systemic rhythmicity could affect OA risk factors in a variety of ways (FIG. 4) . Firstly, an intimate relationship exists between the circadian clock and metabolism 57, 80 . Disruption to the circadian clock, either genetically or environmentally, increases the risk of obesity 81 , which is a major risk factor for metabolic OA 82 . Furthermore, daily cycles of rest and activity are under tight circadian control by the central brain clock. Under normal conditions, the coupling of hypothesis. An inflammatory state is present in osteoarthritis (OA), produced either by the secretion of cytokines from the synovium or, in the context of obesity, indirectly from adipose tissue. These cytokines are involved in the degradation of cartilage by inducing the local secretion of MMPs and ADAMTSs via the activation of signalling pathways, mainly MAPK and NF-κB pathways. Cytokines can also activate the afferent arc of the vagus nerve. After integration of these signals at the brain level, the efferent arc is activated leading to the release of acetylcholine into the microenvironment of the chondrocyte. Acetylcholine binding to its receptors blunts MAPK and NF-kB pathways and thus inhibits cartilage degradation. This cholinergic anti-inflammatory reflex arc can also be externally activated by implanting an external device close to the vagus nerve that delivers electrical stimulation. the circadian phase in gene expression and metabolism with the animal's cycle of rest and activity may be beneficial in weight-bearing tissues. Consequently, circadian rhythms may have evolved in order to ensure temporal segregation of the clean-up (for example, by MMPs and ADAMTS proteases) and the rebuilding phases (involving TIMPs) in joints, so that the two opposing processes do not interfere with one other 46 . Although not proven in joint tissues yet, this hypothesis is supported by studies in other tissues, such as the skin. Across 24 h in human skin, five successive waves of gene expression occur, presenting distinct 'windows' for responses to proliferation, avoidance of DNA damage or repair following DNA damage 83 . Loss of precision in circadian rhythm during ageing could lead to a misalignment of physical activity cycles (controlled by brain clocks) with the optimum circadian phase of joint tissues (determined by local clocks). As a result, the local joint tissues would respond inappropriately to rhythmic challenges, such as mechanical loading associated with daily locomotion, or other systemic cues. This decoupling would result in increased susceptibility to injuries, another key initiating factor for OA development 84 . Currently, it is unknown whether shift workers are at higher risk of developing OA. However, the notion of clock desynchrony in OA development is supported by the observation that a 'chronic jet lag' schedule in mice predisposes to OA-like cartilage degeneration 85 . Of note, is that these mice that were subjected to weekly lightdark cycle reversal still maintained their normal levels of activity, although they failed to align their activity patterns to the constantly changing light conditions.
One caveat of studies involving shift work or jet lag is the confounding systemic and metabolic factors, making it harder to disentangle primary versus secondary causes. In the past year, our group has reported a study involving a mouse model with conditional, tissue-specific ablation of joint clocks (in an otherwise rhythmic body environment) 59 . Loss of BMAL1 in chondrocytes led to global dysregulation of gene expression patterns, lending further support to a critical, and possibly primary, role of clock factors in cartilage health 59 . Global or conditional clock mutant animal models for almost every clock gene have been generated. Therefore, it would be of great interest to test OA susceptibility in these mouse models
. This research would also help to tease out gene-specific versus clock-rhythm-related effects of clock factors in OA pathogenesis.
How ageing disrupts central and peripheral circadian rhythms remains largely unknown; however, a number of experimental studies have suggested that SIRT1 (a protein deacetylase involved in ageing, stress response and energy metabolism) may be critical for ageingdependent decline in both central circadian function and peripheral pacemakers. Levels of SIRT1 mRNA and proteins are downregulated during ageing and in OA 86, 87 , and disruption of SIRT1 expression exacerbates experimental OA in mice [87] [88] [89] . Interestingly, age-related decline in SIRT1 expression has also been implicated as a cause of circadian disruption in the SCN in mice 90 . Remarkably, the expression of the Nampt mouse gene, the rate limiting enzyme controlling synthesis of the SIRT1 substrate NAD + , has a circadian rhythm in cartilage and liver 50, 91 . This clock-controlled regulation leads to the circadian oscillation of NAMPT enzymatic activity and, ultimately, that of NAD +91-94 . Conceivably, in the aged brain and joint tissues, changes in SIRT1 expression and circadian clock disruption could interact to increase OA susceptibility; reduced activity of SIRT1 will dampen the amplitude of molecular clocks, or reciprocally, circadian disruption of NAMPT expression can disrupt SIRT1 activity. Future studies are needed to evaluate the two-way interactions between these factors in the joint during ageing and OA development
The nervous system, circadian clocks and metabolic diseases. Central and peripheral clocks control some crucial metabolic pathways, and metabolism feeds back to the clock machinery 95 . Plasma levels of glucose and lipids display daily oscillations due to rhythmic levels of insulin, glucagon and other hormones 96, 97 . The main adipokines that control fat mass (including leptin, adiponectin and ghrelin) are also controlled by circadian rhythms [98] [99] [100] . Not surprisingly, mice with abnormalities in the function or expression of clock genes show metabolic disturbances 74, 101 . Unfortunately, experimental OA has not been studied in these models (for example, ClockΔ19 mutants or REV-ERB knockout mice). Interestingly, in the opposite direction, the central circadian clock in the brain is regulated by metabolic and nutrient cues 95, 100 . For instance, mice fed a high-fat diet show changes in their circadian period 101, 102 . During ageing, circadian rhythms deteriorate, leading to increased propensity to obesity, which is a major risk factor for metabolic osteoarthritis (OA). Disrupted circadian rhythms in old age is also associated with altered diurnal patterns and reduced levels of physical activity, further contributing to OA pathogenesis. Age-related decline of local clock functions within the joint can have more direct detrimental effects on the homeostasis of joint tissues. ANS, autonomic nervous system; HPA axis, hypothalamic-pituitary-adrenal axis; HPT axis, hypothalamic-pituitary-thyroid axis.
Clinical implications
Several compounds targeting the nervous system, such as antibodies targeting nerve growth factor (NGF) 103 , inhibitors of TrkA (the high-affinity NGF receptor) 104 and CR4056 (a competitive ligand of I 2 binding sites of the imidazoline receptor) 105 , are being tested in OA but only for symptom relief. These new findings about a potential role of the nervous system in OA pathophysiology create new opportunities to develop disease-modifying OA interventions. As an example, stimulation of the vagal nerve with an implanted device has been tested in rats with collagen-induced arthritis with success 106 (FIG. 2) . Histological scores of arthritis were significantly ameliorated with improvements in inflammation, pannus formation, cartilage destruction and bone erosions. This approach is now being tested in many other inflammatory diseases 107 , although no data have been published yet in OA
The knowledge that rhythmic genes in joint tissues are under the control of both the central brain clock and peripheral oscillators, and that circadian control declines with ageing, opens up the possibility of targeting the circadian system systemically or locally to ameliorate age-related changes and perhaps OA susceptibility. For example, improving systemic time cues, such as regular meal times, or periodic warming of the affected joint, may be useful approaches to minimize or correct age-related loss of circadian function. Of note is that the circadian system in flies has been identified as mechanosensitive 56, 108 . If mechanical stimulation can re-entrain the joint clock (either directly or indirectly through the brain), perhaps a regular daily schedule of gentle exercise 109, 110 would benefit local joint rhythms. The rhythmic nature of the diverse pathways in joint tissues suggests that many drug targets could be rhythmically expressed or active during certain parts of the day 111 . Future clinical trials of certain drugs should probably take into account the time of day of drug delivery. In the past decade, compounds that target molecular components of the circadian clock (such as the CRY proteins, casein kinase 1 enzymes and REV-ERB nuclear hormone receptors) have been described [112] [113] [114] [115] . Although these compounds are in the early stages of their development against metabolic disorders or inflammation, they are likely to bring clinical benefits in other diseases in future. Chronotherapy, the concept of delivering drugs according to body clock time, could have considerable clinical benefits in terms of maximizing drug efficacy and consequently reducing drug dose and hence toxicity 116 . In this regard, a double-blind, crossover chronotherapeutic trial of different dosing times of indomethacin to manage OA pain was performed about 30 years ago 117 . The results demonstrated quadrupled tolerance and doubled analgesic effectiveness of a chronotherapeutic dosing regimen.
Conclusions
After decades of research, it has become clear that OA is not simply due to 'wear and tear' . Instead, OA is an active disease of the whole joint that is subject to both local and brain-controlled systemic regulation. The nervous system controls key aspects of joint pathophysiology by regulating circadian rhythms, metabolism and inflammatory pathways. Of particular interest are the emerging roles of circadian rhythms in temporally coordinating joint physiology to the daily rhythmic environment (light-dark and feeding-fasting cycles, and 24 h cycles of core body temperature regulation and mechanical loading). This innovative and integrative view of OA pathophysiology in relation to the brain-joint axis provides a new dimension to conventional OA research, and provides new avenues for identifying novel therapeutic targets 118 . Conceivably, disruptions to the biological timing system or nervous system could be a risk factor for OA susceptibility. Consequently, therapeutic strategies that take into account body clock mechanisms could prove more effective in treating OA. Future research in this area (BOX 1) will no doubt advance our understanding of the brain-joint axis in OA, and identify new routes for OA management.
Box 1 | Research agenda on the brain-joint axis in osteoarthritis
• Collect epidemiological evidence linking the nervous system and/or circadian rhythm disruptions to the incidence of osteoarthritis (OA) in population studies, questionnaire studies, genome-wide association studies and meta-analysis, etc.
• Establish the cause-effect relationship using genetic studies in animal models (such as tissue-specific ablation of individual clock components or receptors for neurotransmitters) • Investigate changes in the nervous system and/or circadian clocks in OA models and patient samples • Test interventions (systemic approaches, pharmacological compounds or chronotherapeutic dosing of drugs) that target the nervous system and/or circadian clocks in preclinical models of OA • Test nervous-system-based interventions, such as the activation of the parasympathetic system, as a beneficial approach for OA • Assess individually the balance of sympathetic and parasympathetic tone in patients as a prognostic biomarker • Stratify human patients with OA according to their circadian phenotype (e.g. questionnaire studies to assess the time of peak pain and early or late chronotypes) for subsequent trial design
